MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Show more
Balance Sheets Overview
Current Ratio
229.48%
Quick Ratio
218.43%
Cash Ratio
68.00%
Debt to Asset Ratio
38.32%
Unit: Million (M) dollars
Assets Breakdown
Investments
Investments, non-current
Cash and cash equivalents
Right-of-use assets, operating l...
Liabilities Breakdown
Retained earnings
Accrued liabilities
Additional paid-in capital
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
1,723
1,908
2,595
1,132
Investments
3,415
3,297
3,204
3,372
Accounts receivable, net
17
71
184
1,046
Inventory
280
146
153
332
Prepaid expenses and other current assets
380
348
408
716
Total current assets
5,815
5,770
6,544
6,598
Investments, non-current
1,772
2,251
2,336
2,143
Property, plant and equipment, net
2,059
2,086
2,134
2,126
Right-of-use assets, operating leases
697
706
719
738
Other non-current assets
618
675
605
530
Total assets
10,961
11,488
12,338
12,135
Accounts payable
167
161
317
267
Accrued liabilities
1,909
1,912
1,386
1,178
Deferred revenue
295
102
99
163
Other current liabilities
163
220
185
73
Total current liabilities
2,534
2,395
1,987
1,681
Deferred revenue, non-current
147
154
153
157
Operating lease liabilities, non-current
638
645
653
660
Financing lease liabilities, non-current
6
13
20
26
Long-term debt
591
590
590
-
Other non-current liabilities
284
283
285
281
Total liabilities
4,200
4,080
3,688
2,805
Additional paid-in capital
1,644
1,503
1,382
1,254
Accumulated other comprehensive income
19
25
45
27
Retained earnings
5,098
5,880
7,223
8,049
Total stockholders equity
6,761
7,408
8,650
9,330
Total liabilities and stockholders equity
10,961
11,488
12,338
12,135
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Investments
$3,415M
(-11.34%↓ Y/Y)
Cash and cash
equivalents
$1,723M
(34.71%↑ Y/Y)
Prepaid expenses and
other current assets
$380M
(-50.26%↓ Y/Y)
Inventory
$280M
(16.67%↑ Y/Y)
Accounts receivable, net
$17M
(-52.78%↓ Y/Y)
Total current assets
$5,815M
(-5.77%↓ Y/Y)
Property, plant and
equipment, net
$2,059M
(-5.07%↓ Y/Y)
Investments, non-current
$1,772M
(-25.36%↓ Y/Y)
Right-of-use assets,
operating leases
$697M
(-7.07%↓ Y/Y)
Other non-current
assets
$618M
(13.19%↑ Y/Y)
Total assets
$10,961M
(-8.73%↓ Y/Y)
Total liabilities and
stockholders equity
$10,961M
(-8.73%↓ Y/Y)
Total stockholders
equity
$6,761M
(-28.07%↓ Y/Y)
Total liabilities
$4,200M
(60.86%↑ Y/Y)
Retained earnings
$5,098M
(-38.20%↓ Y/Y)
Additional paid-in capital
$1,644M
(45.87%↑ Y/Y)
Accumulated other
comprehensive income
$19M
(-17.39%↓ Y/Y)
Total current
liabilities
$2,534M
(61.20%↑ Y/Y)
Operating lease
liabilities, non-current
$638M
(-4.20%↓ Y/Y)
Long-term debt
$591M
Other non-current
liabilities
$284M
(2.90%↑ Y/Y)
Deferred revenue,
non-current
$147M
(126.15%↑ Y/Y)
Financing lease
liabilities, non-current
$6M
(-81.25%↓ Y/Y)
Accrued liabilities
$1,909M
(93.41%↑ Y/Y)
Deferred revenue
$295M
(35.32%↑ Y/Y)
Accounts payable
$167M
(-4.57%↓ Y/Y)
Other current
liabilities
$163M
(-15.10%↓ Y/Y)
Buy us a coffee
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)